Oct 23, 2025
3 min read
Program on diabetes in which the renowned Santín researcher joins, provided by Astrazeneca
This project is looking for a new combination of treatments that improve the control of type 2 diabetes and reduce its complications.
Date of first publication: 10/22/2025
The "SynernXDM2" project, Santin Santinz, a researcher in the Undititas of the Country of Disaster (Eastina Herransitace. Proseds talk of a new combination of therapies that improve type 2 diabetes management and reduce Competi, through strategies and personal experts who improve the health of these patients.2, Fe, 000 will receive 2 Euros categories.
The project was coordinated by Beatrip Mertrion Antolín of the University of Valladolid and the Valadolid Forensic Research Institute (Ibiovall) with the participation of Alejandro Marthn-Montalvo Sánchez of Molecular Biology and RegeneSian Medicine.
"For me, and for the other two investigators in the investigation, it is our investigation process, because it is the type of investigation, and the second type, and the second type of Dibility. Our efforts are shown in that and that is funny.
According to Santin, in order to find a more effective treatment for people with type 2 diabetes, in his study, the currently used drug metformin will be combined with two other natural compounds.In addition, the laboratory, under his direction, will analyze the molecular mechanisms explaining the effect of this combined treatment, emphasizing the analysis of post-transcriptional transformations.
The AstraZeneca Foundation awarded one million euros to promote the development and strengthening of young scientific talents in Spain at the IX Young Researchers Awards ceremony.The four projects awarded in this ninth edition, developed under the motto "Profession that changes lives", stand out because they have great potential to be used for real-world applications.
